ConductScience.org, home

Paper17523697

Calcineurin inhibitors in pediatric renal transplant recipients.

Filler G. Paediatr Drugs, 2007. Cited by 30 papers, by iCite.

Cite this record

ConductScience Library. Calcineurin inhibitors in pediatric renal transplant recipients. Papers, record 17523697. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/17523697

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Calcineurin inhibitors in pediatric renal transplant recipients.
PubMed
Journal
Paediatr Drugs
PubMed
Year
2007
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Review
PubMed
Citations, by iCite
30
iCite
Relative citation ratio, by iCite
1.09
iCite
Revised in PubMed
2022-04-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Filler GGuido

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Calcineurin InhibitorsMajor topic
CyclosporineMajor topic
Graft RejectionMajor topic
Immunosuppressive AgentsMajor topic
Kidney TransplantationMajor topic
TacrolimusMajor topic
Child
Humans
Randomized Controlled Trials as Topic

Source PubMed

Download CSV of topics

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
112176634One-year glomerular filtration rate predicts graft survival in pediatric renal recipients: a randomized trial of tacrolimus vs cyclosporine microemulsion.Transplant Proc2002https://conductscience.org/library/papers/12176634PubMed
216235347Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients.Cochrane Database Syst Rev2005https://conductscience.org/library/papers/16235347PubMed
37506654Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.Drugs1993https://conductscience.org/library/papers/7506654PubMed
416003231A randomized, prospective, pharmacoeconomic trial of tacrolimus versus cyclosporine in combination with thymoglobulin in renal transplant recipients.Transplantation2005https://conductscience.org/library/papers/16003231PubMed
57988626Cyclosporine pharmacokinetics in nephrotic and kidney-transplanted children.Eur J Clin Pharmacol1994https://conductscience.org/library/papers/7988626PubMed
616157605Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.BMJ2005https://conductscience.org/library/papers/16157605PubMed
714961991Post-transplant infections now exceed acute rejection as cause for hospitalization: a report of the NAPRTCS.Am J Transplant2004https://conductscience.org/library/papers/14961991PubMed
812234317Patient survival after renal transplantation: IV. Impact of post-transplant diabetes.Kidney Int2002https://conductscience.org/library/papers/12234317PubMed
99269646Pharmacokinetics of tacrolimus (FK 506) in children and adolescents with renal transplants.Nephrol Dial Transplant1997https://conductscience.org/library/papers/9269646PubMed
109195117Cyclosporin pharmacokinetics in paediatric transplant recipients.Clin Pharmacokinet1997https://conductscience.org/library/papers/9195117PubMed
1111956848Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.Pediatr Nephrol2002https://conductscience.org/library/papers/11956848PubMed
1216048603Four-year data after pediatric renal transplantation: a randomized trial of tacrolimus vs. cyclosporin microemulsion.Pediatr Transplant2005https://conductscience.org/library/papers/16048603PubMed
131373536Morphological and functional changes of islets of Langerhans in FK506-treated rats.Transplantation1992https://conductscience.org/library/papers/1373536PubMed
1415265168Hypertension and end-organ damage in pediatric renal transplantation.Pediatr Transplant2004https://conductscience.org/library/papers/15265168PubMed
1515834618Long-term outcomes of children with end-stage renal disease.Pediatr Nephrol2005https://conductscience.org/library/papers/15834618PubMed
1614710781Current immunosuppressive agents: efficacy, side effects, and utilization.Pediatr Clin North Am2003https://conductscience.org/library/papers/14710781PubMed
177691501Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.Drugs1993https://conductscience.org/library/papers/7691501PubMed
1815041300Cyclosporine as a milestone in immunosuppression.Transplant Proc2004https://conductscience.org/library/papers/15041300PubMed
1912581323Glomerular filtration rate as a putative 'surrogate end-point' for renal transplant clinical trials in children.Pediatr Transplant2003https://conductscience.org/library/papers/12581323PubMed
2015367278What is the calcineurin inhibitor of choice for pediatric renal transplantation?Pediatr Transplant2004https://conductscience.org/library/papers/15367278PubMed

See all 53 referencesDownload CSV of references

Cited by17

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.

PMIDTitleJournalYearIn PapersSource
41599206Population Pharmacokinetics Model of Cyclosporin A in Children and Young Adult Renal Transplant Patients: Focus on Haemoglobin Contribution to Exposure Variability.Pharmaceutics2026https://conductscience.org/library/papers/41599206PubMed
40229569Donor-derived cell-free DNA testing in pediatric kidney transplant recipients: indications and clinical utility.Pediatr Nephrol2025https://conductscience.org/library/papers/40229569PubMed
37665282Ionized Magnesium Correlates With Total Blood Magnesium in Pediatric Patients Following Kidney Transplant.Ann Lab Med2024https://conductscience.org/library/papers/37665282PubMed
36676680Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety.Medicina (Kaunas)2022https://conductscience.org/library/papers/36676680PubMed
35631618Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update.Pharmaceutics2022https://conductscience.org/library/papers/35631618PubMed
35018303An Unusual Presentation of Posterior Reversible Encephalopathy Syndrome Following Liver Transplantation.Transplant Direct2022https://conductscience.org/library/papers/35018303PubMed
31897714Management of dyslipidemia in pediatric renal transplant recipients.Pediatr Nephrol2021https://conductscience.org/library/papers/31897714PubMed
31840013Predicting Health Care Utilization and Charges Using a Risk Score for Poor Adherence in Pediatric Kidney Transplant Recipients.Clin Pract Pediatr Psychol2018https://conductscience.org/library/papers/31840013PubMed
31507644Tuberculum sellae meningioma with possible tacrolimus neurotoxicity manifesting as manic-like psychosis after kidney transplantation.Ann Gen Psychiatry2019https://conductscience.org/library/papers/31507644PubMed
28828166Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes.Int J Organ Transplant Med2017https://conductscience.org/library/papers/28828166PubMed
28507917Systemic meta-analysis assessing the short term applicability of early conversion to mammalian target of rapamycin inhibitors in kidney transplant.World J Transplant2017https://conductscience.org/library/papers/28507917PubMed
27721357Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients.Pharmaceutics2010https://conductscience.org/library/papers/27721357PubMed
26921212The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.Pediatr Nephrol2017https://conductscience.org/library/papers/26921212PubMed
24861769Therapeutic monitoring of pediatric renal transplant patients with conversion to generic cyclosporin.Int J Clin Pharm2014https://conductscience.org/library/papers/24861769PubMed
23690247Refractory intracranial hypertension in posterior reversible encephalopathy syndrome.Neurocrit Care2013https://conductscience.org/library/papers/23690247PubMed
20872191Myoblast transplantation: a possible surgical treatment for a severe pediatric disease.Surg Today2010https://conductscience.org/library/papers/20872191PubMed
18228043Nephrotoxicity as a cause of acute kidney injury in children.Pediatr Nephrol2008https://conductscience.org/library/papers/18228043PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/17523697

GET https://conductscience.org/api/papers/v1/17523697/references?page=2